| CPC C07D 471/16 (2013.01) [C07B 57/00 (2013.01); C07C 235/74 (2013.01); C07C 309/30 (2013.01); C07C 309/35 (2013.01); C07B 2200/07 (2013.01); C07B 2200/13 (2013.01)] | 20 Claims |
|
1. A
![]() salt of formula (VI)
![]() (6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′: 4,5]pyrrolo[1,2,3-de]quinoxaline formed with (+)-dibenzoyl-D-tartaric acid mono(dimethylamide),
or
a salt of formula (II)
![]() (6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′: 4,5]pyrrolo[1,2,3-de]quinoxaline formed with hydrochloric acid,
or
the salt of formula (I) lumateperone formed with naphthalene-2-sulfonic acid,
![]() or
the amorphous form of formula (III) lumateperone salt
![]() in which salt the molar ratio of lumateperone and the p-toluenesulfonic acid is 1:1.
|